Detalhe da pesquisa
1.
Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
Clin Infect Dis
; 2024 Mar 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38466720
2.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep
; 73(4): 77-83, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38300853
3.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
JAMA
; 331(5): 408-416, 2024 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38319331
4.
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
Am J Transplant
; 23(10): 1631-1640, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37778868
5.
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
MMWR Morb Mortal Wkly Rep
; 72(29): 793-801, 2023 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37471262
6.
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023.
MMWR Morb Mortal Wkly Rep
; 72(24): 657-662, 2023 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37319020
7.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
MMWR Morb Mortal Wkly Rep
; 72(7): 177-182, 2023 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36795625
8.
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
MMWR Morb Mortal Wkly Rep
; 72(5): 119-124, 2023 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36730051
9.
Serum per- and polyfluoroalkyl substance concentrations and longitudinal change in post-infection and post-vaccination SARS-CoV-2 antibodies.
Environ Res
; 239(Pt 1): 117297, 2023 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37816422
10.
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 109-117, 2022 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35085226
11.
Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species - United States, January 2016-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(37): 1169-1173, 2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36107787
12.
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(48): 1526-1530, 2022 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36454688
13.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36264840
14.
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance.
JAMA
; 327(11): 1032-1041, 2022 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35157002
15.
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
JAMA
; 327(7): 639-651, 2022 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35060999
16.
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
JAMA
; 327(22): 2210-2219, 2022 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35560036
17.
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.
MMWR Morb Mortal Wkly Rep
; 70(11): 396-401, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33735160
18.
Effectiveness of Homologous and Heterologous Covid-19 Boosters against Omicron.
N Engl J Med
; 386(25): 2433-2435, 2022 06 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35613039
19.
Longitudinal parental perception of COVID-19 vaccines for children in a multi-site, cohort study.
Vaccine
; 42(7): 1512-1520, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38307743
20.
Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions.
Vaccine
; 2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38129285